一个CIA策略,具有卓越的药物装载能力,用于瘤铁灭气体协同疗法
Jiaoyang Zhu1, Lin Huang1, Jing Yang1
1Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, 1023 Shatai South Road, Baiyun, Guangzhou, Guangdong 510515, China.
Theranostics
|December 11, 2024
概括
控制的理想聚合 (CIA) 防止用MRI对比剂的药物聚合. 这种新型纳米粒子系统有效地为协同瘤铁和气体疗法提供药物,提高治疗效率.
科学领域:
- 纳米技术和材料科学 材料科学
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
背景情况:
- 使用MRI对比剂 (CA) 的药物加载和输送在高度下面临聚合挑战.
- 控制的理想聚合 (CIA) 被提出作为一个策略来缓解这个问题.
研究的目的:
- 开发一项针对MRI CA的受控理想聚合 (CIA) 的通用策略,以提高药物加载和输送.
- 创建一个纳米粒子系统,用于协同瘤铁和气体治疗,并实时进行MRI监测.
主要方法:
- Fe2+,β-Lapachone (LAP),brequinar (BQR) 或Sorafenib (SOR) 被装载到Gd多 (酸) 宏酸 (GP),一个MRI CA,在化物修饰的空心半孔性有机纳米颗粒 (HMON-SNO) 中.
- HMON-SNO空心控制聚合,防止过早的药物泄漏.
- 对FeGP@HMON-SNO纳米颗粒进行了瘤铁灭诱导和MRI监测的评估.
主要成果:
- HMON-SNO空心成功地限制了负载剂的聚合和沉.
- 在瘤微环境中,GSH触发了HMON-SNO降解,释放了NO,Fe2+和GP.
- 释放的Fe2+和H2O2产生基基 (•OH),而NO诱导线粒体功能障碍,促进铁亡.
- 医生提供了高对比度T1加权MRI,用于在体内跟踪纳米粒子输送.
结论:
- 美国中央情报局的策略有效地防止了MRI的CA聚合在高药物负载.
- 开发的FeGP@HMON-SNO纳米颗粒显示出高的药物载荷能力.
- FeGP@HMON-SNO启用了有效的协同作用的瘤铁和气体治疗与实时MRI监测.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.3K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K